MariMed Inc. (MRMD) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
MariMed Inc. (MRMD) Q1 2026 Earnings Call Transcript
MariMed Inc. (MRMD) came out with a quarterly loss of $0.01 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.01 per share a year ago.
| Specialty Retail Industry | Consumer Discretionary Sector | Jon R. Levine CEO | NEO-L Exchange | US56782V1070 ISIN |
| US Country | 715 Employees | - Last Dividend | - Last Split | - IPO Date |
MariMed Inc. is a distinguished entity in the cannabis industry, focusing on the cultivation, production, and dispensing of both medicinal and recreational cannabis across the United States and internationally. With its incorporation in 2011 and headquarters in Norwood, Massachusetts, MariMed has carved a niche for itself by offering a wide range of high-quality cannabis products under several well-recognized brands. The company operates with a commitment to excellence and innovation in the cannabis space, ensuring that it meets the diverse needs of its customers through exceptional product offerings and services.